Durham, NC – According to filings with the U.S. Securities and Exchange Commission, Deep Blue Medical Advances is raising $3,523,734.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, William Perry played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Deep Blue Medical Advances

Deep Blue has developed a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line Hernia Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure. Our surgeon-invented T-Line Hernia Mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation the mesh, suture, tissue interface and to provide superior anchor strength.

To learn more about Deep Blue Medical Advances, visit http://www.deepbluemedical.com/

Contact:
William Perry, Chief Executive Officer
408-242-9323

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved